Evolus (EOLS) Net Cash Flow (2017 - 2026)
Evolus (EOLS) reported Net Cash Flow of -$4.0 million for Q1 2026, up 78.96% on a YoY basis from -$2.2 million in Q1 2025, and down 137.47% quarter-over-quarter from $10.7 million in Q4 2025.
Evolus (EOLS) Net Cash Flow (2017 - 2026) Analysis & Trends
Evolus has reported Net Cash Flow for 10 years, with the latest figure at -$4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 78.96% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at -$18.3 million (up 36.49% YoY), and the FY2025 full-year result was -$33.4 million, down 235.74% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$4.0 million, down from $10.7 million in the prior quarter.
- The five-year high for Net Cash Flow was $34.2 million in Q1 2024, with the low at -$39.5 million in Q1 2022.
- Historically, Net Cash Flow has averaged -$5.6 million across 5 years, with a median of -$6.4 million in 2025.
- Annual changes were most pronounced in 2024 — Net Cash Flow slumped 196.6% — and 2025, when it surged 403.42%.
- Evolus' Net Cash Flow stood at -$11.7 million in 2022, then surged by 305.24% to $24.0 million in 2023, then plunged by 91.1% to $2.1 million in 2024, then surged by 403.42% to $10.7 million in 2025, then slumped by 137.47% to -$4.0 million in 2026.
- The last three Net Cash Flow figures came in at -$4.0 million (Q1 2026), $10.7 million (Q4 2025), and -$18.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | -4.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02 Mn |
| Mar 31, 2026 | -4.02 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Sep 30, 2025 | -18.60 Mn |
| Sep 30, 2025 | -18.60 Mn |
| Jun 30, 2025 | -6.40 Mn |
| Jun 30, 2025 | -6.40 Mn |
| Mar 31, 2025 | -19.12 Mn |
| Mar 31, 2025 | -19.12 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | -8.55 Mn |
| Sep 30, 2024 | -8.55 Mn |
| Jun 30, 2024 | -3.24 Mn |
| Jun 30, 2024 | -3.24 Mn |
| Mar 31, 2024 | 34.25 Mn |
| Mar 31, 2024 | 34.25 Mn |
| Dec 31, 2023 | 23.97 Mn |
| Dec 31, 2023 | 23.97 Mn |